Bright Minds Biosciences Inc (DRUG)
SG&A Expense Growth
-0.57%
Quarterly · Period ending:
DRUG SG&A Expense Growth
Latest reported-0.57%period ending
Latest reported-0.57%period ending
DRUG Quarterly SG&A Growth (QoQ) (0.00% → -0.57%)
Latest values, visible window
High-resolution chart · PNG
DRUG sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -0.5714% | |
| 104.6658% | |
| 43.9987% | |
| 27.7849% | |
| -12.4562% | |
| 25% | |
| 54.1053% | |
| 9.4709% | |
| -11.8129% | |
| -9.3688% | |
| -12.6279% | |
| 20.7297% | |
| -32.4037% | |
| -29.4665% | |
| 85.1378% | |
| -28.5799% | |
| -5.8221% | |
| -26.9044% | |
| 17.6338% | |
| -16.0152% | |
| 97.4107% | |
| 113.416% | |
| 120.1868% | |
| 409.088% | |
| 11,014.2012% | |
| 141.4286% | |
| 0% |